Evidence map›Paper›PMID 27241582›Full record

ArticleDrug development research2016

Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model.

Masanori Sugimoto, Yoshihisa Toda, Miyuki Hori, Akiko Mitani, Takahiro Ichihara, Shingo Sekine, Shinsuke Kaku, Noboru Otsuka, Hideo Matsumoto

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Drug development research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Masanori SugimotoResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Yoshihisa TodaResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Miyuki HoriResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Akiko MitaniResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Takahiro IchiharaResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Shingo SekineResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Shinsuke KakuResearch Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Noboru OtsukaDevelopment Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japan.
Hideo MatsumotoInstitute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Taisho Pharmaceutical (Japan) · JPKeio University · JPTaisho Pharmaceutical (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preclinical Research The aim of this study was to evaluate the efficacy of multiple applications of S(+)-flurbiprofen plaster (SFPP), a novel Nonsteroidal anti-inflammatory drug (NSAID) patch, for the alleviation of inflammatory pain and edema in rat adjuvant-induced arthritis (AIA) model as compared to other NSAID patches. The AIA model was induced by the injection of Mycobacterium butyricum and rats were treated with a patch (1.0 cm × 0.88 cm) containing each NSAID (SFP, ketoprofen, loxoprofen, diclofenac, felbinac, flurbiprofen, or indomethacin) applied to the paw for 6 h per day for 5 days. The pain threshold was evaluated using a flexion test of the ankle joint, and the inflamed paw edema was evaluated using a plethysmometer. cyclooxygenase (COX)-1 and COX-2 inhibition was evaluated using human recombinant proteins. Multiple applications of SFPP exerted a significant analgesic effect from the first day of application as compared to the other NSAID patches. In terms of paw edema, SFPP decreased edema from the second day after application, Multiple applications of SFPP were superior to those of other NSAID patches, in terms of the analgesic effect with multiple applications. These results suggest that SFPP may be a beneficial patch for providing analgesic and anti-inflammatory effects clinically. Drug Dev Res 77 : 206-211, 2016. © 2016 The Authors Drug Development Research Published by Wiley Periodicals, Inc.

Indexed as

Administration, CutaneousAnalgesicsAnimalsAnti-Inflammatory Agents, Non-SteroidalArthritis, ExperimentalCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsEdemaFlurbiprofenHumansMaleMycobacteriumPainPain ThresholdRatsAnalgesicsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsFlurbiprofenRecombinant Proteinsanalgesicanti-inflammatoryNSAIDsS(+)-flurbiprofen

Identifiers

PMID27241582
PMCPMC5089648
OpenAlexW2410912790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.